Enhance healthcare with advanced genomics

eVai platform enables precise and early diagnosis of Rare Disease ensuring unprecedented accuracy in interpreting genomic variants.

AI-powered Suggested Diagnosis

Guideline-based Classification

Continuous Learning

Disease-driven Variant Prioritization

AI-powered Suggested Diagnosis

Guideline-based Classification

Continuous Learning

Disease-driven Variant Prioritization

By combining artificial intelligence with ACMG, AMP and ClinGen guidelines, the award-winning eVai classifies and prioritizes genomic variants by pathogenicity, suggesting the possible genetic diagnoses


Our breakthrough AI technology goes beyond the “one-gene one-disease” paradigm unlocking new diagnoses through the assessment of the pathogenic variant combinations.

Since 2011 our scientific team has been developing different bioinformatics workflows (DNA-Seq, RNA-Seq, Liquid Biopsy) for customers worldwide.